Dr Reddy's Laboratories Q1 Results
- BSE: 500124
- NSE: DRREDDY
- ISIN: INE089A01031
- Sector: Biotechnology & Drugs
BSE
1,202.40
-6.75 (-0.56%)
-6.75 (-0.56%)Volume69.82 K
Updated: Wed 7 Oct, 2026 | 15:29:24
NSE
1,203.80-4.20 (-0.35%)
-4.20 (-0.35%)Volume1.75 M
Updated: Wed 7 Oct, 2026 | 15:29:20
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹8,099.80 Cr.(-5.51%)
- Operating Profit₹323.30 Cr.(-80.95%)
- Profit After Tax₹444.30 Cr.(-68.67%)
- Operating Margin3.99%(-79.84%)
Note: Comparison is on YoY basis
Quarterly - Dr Reddy's Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 7,776.50 | 7,721.00 | 0.72% | 5,946.80 | 13.12% |
| Depreciation/ Amortization | 536.60 | 557.10 | -3.68% | 380.60 | 12.71% |
| Operating Income | 323.30 | -,174.60 | 0.00% | 1,749.30 | -80.95% |
| Net Income | 444.30 | 220.90 | 101.13% | 1,392.40 | -68.67% |
| Other Operating Expenses Total | 2,201.70 | 2,246.90 | -2.01% | - | 5.47% |
| Net Income Before Taxes | 553.30 | 199.70 | 177.07% | 1,882.60 | -70.96% |
| Total Revenue | 8,099.80 | 7,546.40 | 7.33% | 7,696.10 | -5.51% |
| Selling/ General/ Admin Expenses Total | 1,651.60 | 1,446.80 | 14.16% | 3,384.00 | 9.85% |
| Diluted Normalized EPS | 5.34 | 4.66 | 14.69% | 16.70 | -68.60% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.